2E59
Crystal structure of human MD-2 in complex with lipid IVa
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL38B1 |
Synchrotron site | SPring-8 |
Beamline | BL38B1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2006-10-10 |
Detector | RIGAKU JUPITER 210 |
Wavelength(s) | 1.0000 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 52.795, 52.795, 110.889 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.720 - 2.210 |
R-factor | 0.20842 |
Rwork | 0.206 |
R-free | 0.26326 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2e56 |
RMSD bond length | 0.011 |
RMSD bond angle | 1.495 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 27.720 |
High resolution limit [Å] | 2.200 |
Rmerge | 0.100 |
Number of reflections | 7629 |
<I/σ(I)> | 9.6 |
Completeness [%] | 90.7 |
Redundancy | 11.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.4 | 277 | 15% PEG3350, 40mM Na-citrate, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K |